Quick summary
Phenylethylamine (PEA) is a compound classified as a nootropic and brain health supplement with limited available human clinical evidence. It has been researched for potential effects on mood, cognition, and nervous system activity, but confirmed benefits and usage guidelines are not well-established.
What is it?
Phenylethylamine is a natural monoamine compound that functions as a central nervous system stimulant. It is structurally related to amphetamines and occurs naturally in some foods as well as being produced endogenously in humans. As a dietary supplement, it is investigated for its possible nootropic and mood-modulating properties, though evidence remains preliminary.
How it may work in the body
PEA is thought to modulate brain neurotransmission and nervous system activity, potentially influencing mood and cognitive function. The proposed mechanisms mostly include its action as a neuromodulator or neurotransmitter analog. However, conclusive mechanisms in humans remain insufficiently verified by clinical evidence.
Most mechanistic data comes from in vitro or animal studies, and human clinical trials are limited. Currently, no robust evidence confirms specific modes of action or clinical relevance in people.
Common supplement forms
The supplied evidence does not specify common supplement forms of phenylethylamine. Typically, PEA supplements are available as oral capsules or powders, but this information has not been confirmed in the current evidence.
Typical dosage and how it is used
No established typical or recommended dosage for phenylethylamine exists due to insufficient clinical data. Study dosages and guidelines have not been clearly defined.
There is no official recommended daily intake or dosage guideline for phenylethylamine as a dietary supplement. Supplementation dosage and safety have not been well defined, so caution is warranted.
Natural sources
The evidence does not provide specific information on natural food sources of phenylethylamine. It is known to occur naturally in some foods and is also produced within the human body, but detailed dietary sources or typical intake amounts are not supplied.
Absorption and bioavailability
Information on the absorption and bioavailability of phenylethylamine in humans is not well characterized. There is no evidence supplied regarding differences between supplement forms, enhancers, or inhibitors of absorption.
Potential benefits: what does the evidence say?
| Area | Evidence level | Summary | Limitations |
|---|---|---|---|
| Mood and cognition | Insufficient | Phenylethylamine has been studied for possible effects on mood, cognition, and nervous system function, but available human clinical evidence is limited and inconclusive. | Lack of large, well-designed clinical trials; existing studies have limitations including small sample sizes and mixed results. |
Overall, early evidence suggests potential neuromodulatory activity, but human clinical research remains inadequate to confirm benefits or specify effective usage.
Side effects and safety
No specific common side effects or safety concerns have been clearly documented in the supplied evidence. Safety during pregnancy and breastfeeding has not been established due to lack of data.
No contraindications or toxicity reports were provided, but given the limited information, cautious use is advisable.
Drug and supplement interactions
The available evidence does not detail any known drug or supplement interactions with phenylethylamine. Healthcare providers should be consulted before use, especially if other medications are being taken.
Who should be careful?
People who are pregnant, breastfeeding, have medical conditions, use medications, or are planning surgery should consult a healthcare professional before using phenylethylamine supplements, due to the limited safety data.
Pregnancy, breastfeeding and special populations
Safety of phenylethylamine supplementation during pregnancy and breastfeeding has not been established. No specific data about use in children, elderly, or other special populations is available.
Quality, standardization and what to look for
No information on quality standards or product standardization for phenylethylamine supplements is provided in the evidence. Consumers should select products from reputable manufacturers that adhere to good manufacturing practices (GMP) and offer third-party testing where possible.
Frequently asked questions
- Is phenylethylamine a natural substance? Yes, it is naturally produced in the human body and can be found in some foods.
- Does phenylethylamine improve mood or cognition? Early studies have explored these effects, but evidence in humans is limited and inconclusive.
- Are there official dosage recommendations? No official recommended daily intake or typical dosage exists for phenylethylamine supplements.
- Is it safe to take phenylethylamine supplements? Due to limited safety data, caution is advised, particularly for pregnant or breastfeeding women and those with health conditions.
- Can phenylethylamine interact with medications? No specific interactions are documented, but consulting a healthcare professional before use is recommended.
Evidence limitations
- No robust human clinical trials establishing efficacy or safety.
- Predominantly animal or mechanistic data with limited clinical validation.
- Absence of official intake recommendations or safety guidelines.
References
Last reviewed
June 2024
Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new dietary supplement, especially if you are pregnant, breastfeeding, have existing health conditions, use medications, or are planning surgery.